Pune, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
Immuno-Oncology Market report analysis benefits to shape the competition within the businesses and policies for the competitive environment to improve the possible revenue. The report evaluates key opportunities in the market and plans the factors that are and will drive the progress of the industry. Taking into account earlier growing patterns, growth drivers, and existing and upcoming trends, we also estimate the overall development of the global Immuno-Oncology market during the forecast period.
Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/21051281
In short, the Immuno-Oncology market report is helpful for industry players, investors, consultants, business strategists, researchers, and all those who is having any kind of interest or are planning to venture into the Immuno-Oncology market in any way.
The global Immuno-Oncology market size is projected to reach USD 116680 million by 2028, from USD 43650 million in 2021, at a CAGR of 14.9% during 2022-2028.
Immuno-Oncology Market Segmentation: -
Market segments help decision-makers direct the product, sales, and marketing strategies, and can power your product development cycles by informing how you make product offerings for different segments.
Segment by Type
- Immune Checkpoint Inhibitors
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Others
Segment by Application
- Hospitals
- Drugstores
- Others
Market segment by Region/Country including: -
- North America (United States, Canada, and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Southeast Asia, etc.)
- South America (Brazil, Argentina, Colombia, etc.)
- Middle East & Africa (South Africa, UAE, Saudi Arabia, etc.)
Inquire or Share Your Questions If Any Before Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/21051281
Key Players in the Immuno-Oncology Market: -
- Bristol-Myers Squibb
- Merck & Co., Inc.
- Roche AG
- AstraZeneca, Plc
- Sanofi S.A.
- Dendreon Pharmaceuticals
- Novartis
- Gilead Sciences Inc.
- Merck KGaA
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
Key Benefits of Immuno-Oncology Market Research Report:
- Types, applications, regions, and key players covered in the study
- Industry drivers, restraints, and opportunities covered in the study
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immuno-Oncology Market
- Sales, price, revenue, market share, and growth rate are covered in the report sales channels, distributors, traders, dealers, etc. are covered in the report
Purchase this Report (Price 2900 USD for a Single-User License) – https://www.absolutereports.com/checkout/21051281
Detailed TOC of Global Immuno-Oncology Market Research Report 2022
1 Report Overview
2 Global Growth Trends
3 Competition Landscape by Key Players
4 Immuno-Oncology Breakdown Data by Type
5 Immuno-Oncology Breakdown Data by Application
6 North America
7 Europe
8 Asia-Pacific
9 Latin America
10 Middle East & Africa
11 Key Players Profiles
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
About Absolute Reports:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
